Insights

Keep up with the latest insights from Norstella and its market-leading brands.

News

Press Release | Jun. 23, 2022

MMIT Announces Winners of the Q1 2022 Patient Access Awards

June 23, 2022, Yardley, PA – Managed Markets Insight & Technology (MMIT)—the trusted go-to-market partner for overcoming barriers to patient access—has launched the inaugural Patient Access Awards to honor pharmaceutical manufacturers committed to improving patient access to life-saving therapies. Read more
Press Release | May. 09, 2022

MMIT Announces the Winners of the Seventh-Annual Specialty Pharmacy Patient Choice Awards

May 9, 2022, Yardley, PA – Managed Markets Insight & Technology (MMIT)—the trusted go-to-market partner for overcoming barriers to patient access—has announced the winners of the seventh-annual Specialty Pharmacy Patient Choice Awards.  Each year, MMIT hosts the Patient Choice Awards to honor specialty pharmacies that provide best-in-class customer satisfaction and overall patient care within four categories: Payer/PBM, Hospital and Health System, Independent and Retail. Read more
Press Release | May. 03, 2022

Four prominent pharmaceutical solutions providers launch Norstella to drive innovation and get patients access to life-saving therapies faster

May 3, 2022 – Creating a hub for rapid innovation, four prominent pharmaceutical solutions providers—Evaluate, MMIT, Panalgo and The Dedham Group—are thrilled to announce the launch of Norstella. Read more

Insights

REPORT | Jul. 30, 2021

Evaluate Pharma World Preview 2021: Outlook to 2026

Evaluate’s comprehensive report tracks the expected performance of the biopharma industry between now and 2026, based on Evaluate Pharma’s coverage of the world’s leading pharmaceutical and biotech companies. Read more
Article | Dec. 21, 2021

Market Access Speed Is the Next Critical Differentiator for Pharma Manufacturers

With the cost of healthcare and drug discovery continuing to rise and value-based contracting gaining traction, demonstrating a product’s economic value compared to existing competitor products is more important than ever. Drugs today need to be reimbursable, not just approvable, writes MMIT’s Dinesh Kabaleeswaran in an article for PharmExec. Read more
Article | Sep. 15, 2021

RWE: Supporting Regulatory Submissions with Real-World Evidence

When submitting RWE, it is crucial for life sciences organizations to not only feel confident in the data they provide, but also that it will be accepted by regulatory reviewers, writes Panalgo’s Tiffany Siu Woodworth. The main question these companies must ask themselves is, how can we trust the evidence we are providing? Read more
Press Release | May. 03, 2022

Four prominent pharmaceutical solutions providers launch Norstella to drive innovation and get patients access to life-saving therapies faster

May 3, 2022 – Creating a hub for rapid innovation, four prominent pharmaceutical solutions providers—Evaluate, MMIT, Panalgo and The Dedham Group—are thrilled to announce the launch of Norstella. Read more
Press Release | Apr. 27, 2021

MMIT & The Dedham Group Unite to Smooth Access to Therapy

The combined data, technologies and expertise of both organizations will positively impact patient access to life saving treatments April 27, 2021, Yardley, PA – Managed Markets Insight & Technology, LLC. (MMIT), the trusted go-to-market partner solely focused on solving the “what and why” of market access—so that patients don’t face delays when trying to access lifesaving […] Read more

Events

Work with us

Join our mission

We're looking for agile, growth-oriented team players who are passionate about client success and helping patients get access to the therapies they need.

Work with us

Get in Touch

Let's connect

Have questions about Norstella or its brands? Or do you want to know more about how to solve your market access challenges?

We want to hear from you